InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Explore the complete record of transactions filed by HILLEMAN JERYL L, Director. Insider active across 3 companies, notably Omada Health, Inc.. Cumulatively, 11 disclosures have been published. Total volume traded: €301k. The latest transaction was filed on 5 October 2025 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations11 total
01,081 shares0
Common Stock
SEC:0001610717-25-000425·
01,081 shares0
Common Stock
SEC:0001610717-25-000425:0·
08,324 shares0
Common Stock
SEC:0001562180-22-005231:0·
€26,679407 shares@ €65.5510.0018% mcap100.0% of flow
Ordinary Shares
SEC:0001645113-22-000057:0·
€25,5031,924 shares@ €13.25530.0041% mcap9.3% of flow
Common Stock
SEC:0001562180-22-005093:0·
€124,3254,400 shares@ €28.25570.020% mcap100.0% of flow
Common Stock
SEC:0001562180-21-004532·
€124,3254,400 shares@ €28.25570.020% mcap45.3% of flow
Common Stock
SEC:0001562180-21-004532:0·
03,848 shares0
Common Stock
SEC:0001562180-21-004254·
03,848 shares0
Common Stock
SEC:0001562180-21-004254:0·
0814 shares0
Restricted Stock Units
SEC:0001645113-21-000076:0·
0814 shares0
Restricted Stock Units
SEC:0001645113-21-000076·
11 of 11 declarations
About HILLEMAN JERYL L
HILLEMAN JERYL L serves as a Director at Omada Health, Inc., NovoCure Ltd, and SI-BONE, Inc. In this role, he contributes to the governance and strategic direction of these companies. His experience in the healthcare sector allows him to provide valuable insights on growth and innovation opportunities. Jeryl plays a key role in overseeing operations and evaluating company performance.
